Dr. Jonathan R. Strosberg on 177-Lu-Dotatate in Patients With Neuroendocrine Tumors

Video

Jonathan R. Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the targeted, systemic radiation treatment 177-Lu-Dotatate (Lutathera), a somatostatin analogue peptide, in patients with neuroendocrine tumors.

Jonathan R. Strosberg, MD, associate professor, Moffitt Cancer Center, discusses the targeted, systemic radiation treatment 177-Lu-Dotatate (Lutathera), a somatostatin analogue peptide, in patients with neuroendocrine tumors. Strosberg says this targeted therapy is especially useful due to neuroendocrine tumors generally having high-expressing somatostatin expressers.

Recent Videos
Related Content
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers

Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers

Targeted Oncology Staff
December 20th 2024
Article

During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.

Read More

LaPelusa’s Journey in the Dynamic Field of GI Oncology

LaPelusa’s Journey in the Dynamic Field of GI Oncology

Jordyn Sava;Michael LaPelusa, MD
May 1st 2024
Podcast

In this episode of Emerging Experts, Michael LaPelusa, MD, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.

Listen

Standard Belzutifan Dose Equally Effective as Higher Dose in ccRCC

Standard Belzutifan Dose Equally Effective as Higher Dose in ccRCC

Jordyn Sava
December 18th 2024
Article

In an interview with Targeted Oncology, Jaime Merchan, MD, delved into data from the LITESPARK-013 trial evaluating belzutifan for advanced clear cell renal cell carcinoma treatment.

Read More

Unpacking the Latest Research in Gastrointestinal Cancers

Unpacking the Latest Research in Gastrointestinal Cancers

Nichole Tucker;Benjamin L. Schlechter, MD
February 15th 2023
Podcast

In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, discuses new studies in the gastrointestinal cancers space.

Listen

Biomarkers and Treatment Strategies in CAR T-Cell Therapy for R/R Multiple Myeloma

Biomarkers and Treatment Strategies in CAR T-Cell Therapy for R/R Multiple Myeloma

Jordyn Sava
December 14th 2024
Article

Doris K. Hansen, MD, discussed a comprehensive analysis of pretreatment biomarkers associated with outcomes in patients receiving idecabtagene vicleucel therapy

Read More

AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis

AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis

Jordyn Sava
December 10th 2024
Article

In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.

Read More